• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Arena Pharmaceuticals Inc

+ Add to Watchlist

ARNA:US

6.3000 USD 0.0500 0.79%

As of 20:10:00 ET on 04/16/2014.

Snapshot for Arena Pharmaceuticals Inc (ARNA)

Open: 6.4000 Day's Range: 6.2100 - 6.4400 Volume: 5,044,999
Previous Close: 6.3500 52wk Range: 4.0500 - 9.2500 1-Yr Rtn: -21.84%

Stock Chart for ARNA

No chart data available.
  • ARNA:US 6.3000
  • 1D
  • 1M
  • 1Y
6.3500
Interactive ARNA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARNA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.1373
Est. EPS (USD) (12/2014) -0.4010
Est. PEG Ratio -
Market Cap (M USD) 1,381.34
Shares Outstanding (M) 219.26
30 Day Average Volume 5,429,964
Price/Book (mrq) 15.0075
Price/Sale (ttm) 16.8735
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/02/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARNA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ARNA

Arena Pharmaceuticals, Inc. is a biotechnology company that has developed a receptor-based screening assay using their own CART technology.

Jack LiefChairman/Pres/CEO/Co-FounderDominic P BehanExec VP/Chief Scientific Ofcr
Steven W SpectorExec VP/General Counsel/SecyRobert E HoffmanSenior VP:Finance/CFO
More Company Profile & Key Executives for ARNA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil